Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 14;60(4):593-596.
doi: 10.1515/cclm-2021-0769. Print 2022 Mar 28.

Biological variation, reference change values and index of individuality of GDF-15

Cindhya Sithiravel  1 , Ragnhild Røysland  1   2 , Bashir Alaour  3 , Marit Sverresdotter Sylte  4 , Janniche Torsvik  4 , Heidi Strand  1 , Michael Marber  3 , Torbjørn Omland  2   5 , Kristin Moberg Aakre  4   6   7
Affiliations

Biological variation, reference change values and index of individuality of GDF-15

Cindhya Sithiravel et al. Clin Chem Lab Med. .
No abstract available

Keywords: analytical performance goal; biomarker; clinical interpretation; diagnosis; monitoring; prognosis.

PubMed Disclaimer

Conflict of interest statement

Competing interests: Kristin M. Aakre has served on advisory boards for Roche Diagnostics and received personal fees from Siemens Healthineers. Torbjørn Omland has served on advisory boards for Abbott Diagnostics, Roche Diagnostics and Bayer and has received research support from Abbott Diagnostics, Novartis, Roche Diagnostics, Singulex and SomaLogic via Akershus University Hospital, and speaker’s or consulting honoraria from Abbott Diagnostics, Roche Diagnostics, Siemens Healthineers and CardiNor. Dr. Omland is also listed as an inventor on a patent application entitled: “GDF-15 for predicting the disease severity of a patient with COVID-19” and on the granted patent applications Granin proteins as markers of heart disease. PCT/GB0818650.4 SgII as a prognostic marker in conditions which require critical care. CT/GB0919901.9. Cindhya Sithiravel, Ragnhild Røysland, Bashir Alaour, Marit S. Sylte, Janniche Torsvik, Heidi Strand, Michael Marber report no conflict of interest.

Figures

Figure 1:
Figure 1:
Median and range of 295 concentrations (ng/L) in the 30 participants. To visualize our data immeasurable values (values
See this image and copyright information in PMC

References

    1. Baek SJ, Eling T. Growth differentiation factor 15 (GDF15): a survival protein with therapeutic potential in metabolic diseases. Pharmacol Ther. 2019;198:46–58. doi: 10.1016/j.pharmthera.2019.02.008. - DOI - PMC - PubMed
    1. Adela DR, Banerjee S. Review article GDF-15 as a target and biomarker for diabetes and cardiovascular diseases: a translational prospective. Jo Diabetic Res. 2015;2015 doi: 10.1155/2015/490842. - DOI - PMC - PubMed
    1. Wollert KC, Kempf T, Wallentin L. Growth differentiation factor 15 as a biomarker in cardiovascular disease. Clin Chem. 2017;63:140–51. doi: 10.1373/clinchem.2016.255174. - DOI - PubMed
    1. Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci. 1989;27:409–37. doi: 10.3109/10408368909106595. - DOI - PubMed
    1. Burtis CA, Ashwood ER, Bruns DE. Tietz textbook of clinical chemistry and molecular diagnostics. 5th ed. USA: Saunders; 2011.

Publication types

Substances

LinkOut - more resources